NCT00066781View on ClinicalTrials.gov

Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

April 30, 2008

Study Completion Date

March 31, 2009

Conditions
Carcinoma of Unknown Primary
Interventions
DRUG

gemcitabine hydrochloride

Given IV

DRUG

irinotecan hydrochloride

Given IV

Trial Locations (4)

50401

Mercy Cancer Center at Mercy Medical Center - North Iowa, Mason City

55905

Mayo Clinic Cancer Center, Rochester

68106

CCOP - Missouri Valley Cancer Consortium, Omaha

68510

Cancer Resource Center - Lincoln, Lincoln

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00066781 - Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary | Biotech Hunter | Biotech Hunter